CIK 0000730272
- Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042729386
- Phone
- +1 781-449-9560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- 4 Grant or award Director acquired 644 shares (grant or award)
- 4 Grant or award Director acquired 534 shares (grant or award)
- 4 Grant or award Director acquired 534 shares (grant or award)
- 4 Grant or award Director acquired 1,024 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 14,715 shares at an average $150.51 ($2,214,819)
- 4 Shares withheld for taxes Senior VP, R&D gave up 712 shares (to pay taxes)
- 4 Shares withheld for taxes Gebski Christine gave up 335 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 712 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 335 shares (to pay taxes)
- 4 Exercise or conversion Chief Financial Officer acquired 4,166 shares (option exercise)
- 4 Shares withheld for taxes Chief Executive Officer gave up 7,292 shares (to pay taxes)
- 4 Open-market sale Director sold 2,000 shares at an average $198.03 ($396,060)
- 4 Shares withheld for taxes Senior VP, R&D gave up 2,534 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 3,824 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 19,292 shares (to pay taxes)
- 4 Shares withheld for taxes Gebski Christine gave up 1,060 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 1,170 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 269 shares (to pay taxes)
- 4 Shares withheld for taxes Senior VP, R&D gave up 188 shares (to pay taxes)
Page 10 of 34 · 669 filings